0 false false false true false false false false false false true false false false false true false 2022-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 268,000 268,000 268,000 418,185 418,185 418,185 xbrli:pure xbrli:shares iso4217:EUR 12484479 2022-03-01 2023-02-28 12484479 2023-02-28 12484479 2022-02-28 12484479 2021-03-01 2022-02-28 12484479 2022-02-28 12484479 2021-02-28 12484479 core:Subsidiary1 2022-03-01 2023-02-28 12484479 bus:Director3 2022-03-01 2023-02-28 12484479 bus:Director1 2022-03-01 2023-02-28 12484479 bus:Director2 2022-03-01 2023-02-28 12484479 bus:CompanySecretary1 2022-03-01 2023-02-28 12484479 bus:Director3 2023-02-28 12484479 bus:Director1 2023-02-28 12484479 bus:Director2 2023-02-28 12484479 core:WithinOneYear 2023-02-28 12484479 core:WithinOneYear 2022-02-28 12484479 core:RetainedEarningsAccumulatedLosses 2021-03-01 2022-02-28 12484479 core:ShareCapital 2022-03-01 2023-02-28 12484479 core:RetainedEarningsAccumulatedLosses 2022-03-01 2023-02-28 12484479 core:ShareCapital 2023-02-28 12484479 core:ShareCapital 2022-02-28 12484479 core:RetainedEarningsAccumulatedLosses 2023-02-28 12484479 core:RetainedEarningsAccumulatedLosses 2022-02-28 12484479 core:ShareCapital 2021-02-28 12484479 core:RetainedEarningsAccumulatedLosses 2021-02-28 12484479 core:PatentsTrademarksLicencesConcessionsSimilar 2023-02-28 12484479 core:PatentsTrademarksLicencesConcessionsSimilar 2022-02-28 12484479 core:CostValuation core:Non-currentFinancialInstruments 2023-02-28 12484479 core:Non-currentFinancialInstruments 2023-02-28 12484479 core:Non-currentFinancialInstruments 2022-02-28 12484479 bus:SmallEntities 2022-03-01 2023-02-28 12484479 bus:AuditExempt-NoAccountantsReport 2022-03-01 2023-02-28 12484479 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 12484479 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12484479 bus:FullAccounts 2022-03-01 2023-02-28
COMPANY REGISTRATION NUMBER: 12484479
WORKATHLON LTD
Unaudited Financial Statements
28 February 2023
WORKATHLON LTD
Financial Statements
Year ended 28 February 2023
Contents
Page
Director's report
1
Income statement
2
Statement of financial position
3
Statement of changes in equity
4
Notes to the financial statements
5
WORKATHLON LTD
Director's Report
Year ended 28 February 2023
The director presents his report and the unaudited financial statements of the company for the year ended 28 February 2023 .
Principal activities
The principal activity of the company during the year was holding of shares and intangible assets
Directors
The directors who served the company during the year were as follows:
Mr. Theofilos Vasileiadis
(Appointed 9 January 2023)
Mrs Aikaterini Santikou
(Resigned 9 January 2023)
Mr Elefterios Santikos
(Resigned 9 January 2023)
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 11 October 2023 and signed on behalf of the board by:
Mr. Theofilos Vasileiadis
Theofilos Vasileiadis
Director
Company Secretary
WORKATHLON LTD
Income Statement
Year ended 28 February 2023
2023
2022
Note
Administrative expenses
( 6,963)
( 9,506)
-------
-------
Operating loss
( 6,963)
( 9,506)
-------
-------
Loss before taxation
( 6,963)
( 9,506)
Tax on loss
-------
-------
Loss for the financial year
( 6,963)
( 9,506)
-------
-------
All the activities of the company are from continuing operations.
The company has no other recognised items of income and expenses other than the results for the year as set out above.
WORKATHLON LTD
Statement of Financial Position
28 February 2023
2023
2022
Note
Fixed assets
Intangible assets
4
268,000
268,000
Investments
5
418,185
418,185
---------
---------
686,185
686,185
Current assets
Debtors
6
2,101
Cash at bank and in hand
150,492
77,442
---------
--------
152,593
77,442
Creditors: amounts falling due within one year
7
185,746
375,733
---------
---------
Net current liabilities
33,153
298,291
---------
---------
Total assets less current liabilities
653,032
387,894
---------
---------
Net assets
653,032
387,894
---------
---------
Capital and reserves
Called up share capital
690,286
418,185
Profit and loss account
( 37,254)
( 30,291)
---------
---------
Shareholders funds
653,032
387,894
---------
---------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 11 October 2023 , and are signed on behalf of the board by:
Mr. Theofilos Vasileiadis
Director
Company registration number: 12484479
WORKATHLON LTD
Statement of Changes in Equity
Year ended 28 February 2023
Called up share capital
Profit and loss account
Total
At 1 March 2021
418,185
( 20,785)
397,400
Loss for the year
( 9,506)
( 9,506)
---------
--------
---------
Total comprehensive income for the year
( 9,506)
( 9,506)
At 28 February 2022
418,185
( 30,291)
387,894
Loss for the year
( 6,963)
( 6,963)
---------
--------
---------
Total comprehensive income for the year
( 6,963)
( 6,963)
Issue of shares
272,101
272,101
---------
----
---------
Total investments by and distributions to owners
272,101
272,101
---------
--------
---------
At 28 February 2023
690,286
( 37,254)
653,032
---------
--------
---------
WORKATHLON LTD
Notes to the Financial Statements
Year ended 28 February 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is St Georges House, 6th Floor, 15 Hanover Square, London, W1S 1HS, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements are prepared in euro, which is the functional currency of the entity.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Intangible assets
Patents, trademarks and licences
Cost
At 1 March 2022 and 28 February 2023
268,000
---------
Amortisation
At 1 March 2022 and 28 February 2023
---------
Carrying amount
At 28 February 2023
268,000
---------
At 28 February 2022
268,000
---------
5. Investments
Shares in group undertakings
Cost
At 1 March 2022 and 28 February 2023
418,185
---------
Impairment
At 1 March 2022 and 28 February 2023
---------
Carrying amount
At 28 February 2023
418,185
---------
At 28 February 2022
418,185
---------
Subsidiaries, associates and other investments
Class of share
Percentage of shares held
Subsidiary undertakings
WORKATHLON SINGLE MEMBER P.C.
Ordinary
100
6. Debtors
2023
2022
Other debtors
2,101
-------
----
7. Creditors: amounts falling due within one year
2023
2022
Trade creditors
5,795
1,867
Accruals and deferred income
1,505
1,580
Workathlon IKE
67,160
141,000
Safe liability account
120,000
Other creditors
111,286
111,286
---------
---------
185,746
375,733
---------
---------